{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:52:15Z","timestamp":1791823935217,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clineuro.2020.106082","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T02:01:56Z","timestamp":1594346516000},"page":"106082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Clinical characteristics and outcomes of autoimmune encephalitis patients associated with anti-glutamate decarboxylase antibody 65"],"prefix":"10.1016","volume":"196","author":[{"given":"Yan-fang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2988-4658","authenticated-orcid":false,"given":"Nian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-jian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clineuro.2020.106082_bib0005","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1212\/WNL.0000000000006990","article-title":"Autoimmune encephalitis: a costly condition","volume":"92","author":"Cohen","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2020.106082_bib0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106082_bib0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/bs.apha.2017.08.005","article-title":"Anti-NMDA receptor encephalitis: clinical features and basic mechanisms","volume":"82","author":"Lynch","year":"2018","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106082_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1684\/epd.2015.0734","article-title":"Autoimmune encephalitis and anti-GAD\/GABA-A receptor antibodies","volume":"17","author":"Simabukuro","year":"2015","journal-title":"Epileptic Disorder"},{"issue":"3","key":"10.1016\/j.clineuro.2020.106082_bib0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.braindev.2018.10.006","article-title":"Severe anti-GAD antibody-associated encephalitis after stem cell transplantation","volume":"41","author":"Nagai","year":"2019","journal-title":"Brain Dev."},{"issue":"4","key":"10.1016\/j.clineuro.2020.106082_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2020.106082_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2020.106082_bib0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nbd.2005.03.016","article-title":"Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration","volume":"20","author":"Stephenson","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.clineuro.2020.106082_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fneur.2015.00167","article-title":"Treating a GAD65 antibody-associated limbic encephalitis with basiliximab: a case study","volume":"6","author":"Widman","year":"2015","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2020.106082_bib0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1212\/CPJ.0000000000000148","article-title":"Anti-GAD antibody syndrome with concomitant cerebellar ataxia, stiff person syndrome, and limbic encephalitis","volume":"5","author":"Schaefer","year":"2015","journal-title":"Neurol. Clin. Pract."},{"issue":"3","key":"10.1016\/j.clineuro.2020.106082_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.17712\/nsj.2016.3.20150596","article-title":"Anti-glutamic acid decarboxylase antibody positive neurological syndromes","volume":"21","author":"Tohid","year":"2016","journal-title":"Neurosciences"},{"issue":"1","key":"10.1016\/j.clineuro.2020.106082_bib0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13023-018-0787-5","article-title":"GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies","volume":"13","author":"Liimatainen","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106082_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2020.106082_bib0070","first-page":"1","article-title":"Autoimmune encephalitis with psychosis: warning signs, step-by-step diagnostics and treatment","volume":"24","author":"Steiner","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"issue":"18","key":"10.1016\/j.clineuro.2020.106082_bib0075","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: Etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.106082_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2019.04.007","article-title":"The neurological syndromes associated with glutamic acid decarboxylase antibodies","volume":"101","author":"Baizabal-Carvallo","year":"2019","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106082_bib0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12883-015-0435-9","article-title":"Long latency between GAD-antibody detection and development of limbic encephalitis-a case report","volume":"15","author":"Fauser","year":"2015","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2020.106082_bib0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/trp.trp_48_17","article-title":"Steroid-responsive encephalopathy in autoimmune thyroiditis: A diagnostic enigma?","volume":"15","author":"Sharma","year":"2018","journal-title":"Thyroid. Res. Pract."},{"issue":"3","key":"10.1016\/j.clineuro.2020.106082_bib0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/neu.2016.49","article-title":"Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica","volume":"29","author":"Pereira","year":"2017","journal-title":"Acta Neuropsychiatr."},{"issue":"4","key":"10.1016\/j.clineuro.2020.106082_bib0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/neup.12283","article-title":"Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: Causality or coincidence?","volume":"36","author":"Niehusmann","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.clineuro.2020.106082_bib0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2018.06.013","article-title":"Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression","volume":"323","author":"Triplett","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clineuro.2020.106082_bib0110","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3389\/fimmu.2018.02708","article-title":"Management of autoimmune encephalitis: an observational monocentric study of 38 patients","volume":"9","author":"Macher","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clineuro.2020.106082_bib0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2020.106082_bib0120","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2020.106082_bib0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2020.106082_bib0130","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672030425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672030425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:37:05Z","timestamp":1759588625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384672030425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"alternative-id":["S030384672030425X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106082","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and outcomes of autoimmune encephalitis patients associated with anti-glutamate decarboxylase antibody 65","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106082"}}